TOPCHOICE MEDICAL CO., INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.42 CNY | -0.82% |
|
-4.16% | -28.82% |
| Sales 2023 * | 2.91B 402M | Sales 2024 * | 3.48B 481M | Capitalization | 17.45B 2.41B |
|---|---|---|---|---|---|
| Net income 2023 * | 587M 81.08M | Net income 2024 * | 754M 104M | EV / Sales 2023 * | 5.72 x |
| Net cash position 2023 * | 811M 112M | Net cash position 2024 * | 1.38B 190M | EV / Sales 2024 * | 4.62 x |
| P/E ratio 2023 * |
28.2
x | P/E ratio 2024 * |
23.1
x | Employees | 5,844 |
| Yield 2023 * |
0.1% | Yield 2024 * |
0.12% | Free-Float | 60.03% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.82% | ||
| 1 week | -4.16% | ||
| Current month | -9.15% | ||
| 1 month | -20.23% | ||
| 3 months | -22.92% | ||
| 6 months | -34.98% | ||
| Current year | -28.82% |
1 week
53.33
56.94
1 month
53.3367.79
Current year
52.5176.88
1 year
52.51124.11
3 years
52.51421.99
5 years
52.51421.99
10 years
17.71421.99
| Managers | Title | Age | Since |
|---|---|---|---|
Yi Wang
CEO | Chief Executive Officer | 56 | 17-10-17 |
Guo Xi Xu
DFI | Director of Finance/CFO | 39 | 14-12-31 |
Hua Zhang
SEC | Corporate Secretary | 59 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jian Ming Lu
CHM | Chairman | 59 | 16-12-29 |
Min Zhao
BRD | Director/Board Member | 57 | - |
Yi Wang
CEO | Chief Executive Officer | 56 | 17-10-17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.82% | 2 M€ | -19.84% | - | |
| 0.45% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 54.42 | -0.82% | 3,935,364 |
| 24-04-17 | 54.87 | +2.20% | 3,807,035 |
| 24-04-16 | 53.69 | -3.70% | 3,879,540 |
| 24-04-15 | 55.75 | +0.22% | 3,439,215 |
| 24-04-12 | 55.63 | -2.03% | 2,522,214 |
End-of-day quote Shanghai S.E., April 17, 2024
More quotes
Topchoice Medical Co Inc, formerly Top choice Medical Investment Co Inc, is a China-based company mainly engaged in medical treatment. The Company operates in three segments. Medical Service segment mainly provides dental medical services, including dental implants, orthodontics and pediatric dental services. Product Sales segment is mainly engaged in the sales of medical equipment. Management services and Others segment is engaged in other management support businesses.
Calendar
2024-04-25
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
54.42
CNY
Average target price
88.78
CNY
Spread / Average Target
+63.15%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -28.82% | 2.41B | |
| -21.35% | 2.93B | |
| -57.13% | 2.2B | |
| -9.98% | 200M | |
| -49.06% | 176M | |
| -27.37% | 124M |
- Stock Market
- Equities
- 600763 Stock
